We are live on ! Find out more
RLAY icon

Relay Therapeutics
RLAY

94 hedge funds and large institutions have $3.64B invested in Relay Therapeutics in 2020 Q3 according to their latest regulatory filings, with 94 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100.36% more ownership

Funds ownership: 0% → 100.36% (+100%)

Holders
94
Holders Change
+94
Holders Change %
–
% of All Funds
1.9%
Holding in Top 10
11
Holding in Top 10 Change
+11
Holding in Top 10 Change %
% of All Funds
0.22%
New
94
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SIAU
SB Investment Advisers (UK)
United Kingdom
+$1.06B
2
TGI
TRV GP III
Massachusetts
+$402M
3
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$216M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$184M
5
CC
Casdin Capital
New York
+$145M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Janus Henderson Group
26
Janus Henderson Group
United Kingdom
$20.7M +$18.6M +486,611 New
State Street
27
State Street
Massachusetts
$20.4M +$18.2M +477,888 New
Geode Capital Management
28
Geode Capital Management
Massachusetts
$18.6M +$16.7M +436,982 New
RSCM
29
Rock Springs Capital Management
Maryland
$17.6M +$15.8M +413,674 New
AG
30
Artal Group
Luxembourg
$17M +$15.3M +400,000 New
Northern Trust
31
Northern Trust
Illinois
$15.2M +$13.7M +358,058 New
WP
32
Woodline Partners
California
$15M +$13.4M +351,823 New
O
33
OrbiMed
New York
$14.9M +$13.3M +350,000 New
ACH
34
ArrowMark Colorado Holdings
Colorado
$14.7M +$13.2M +344,954 New
UBS AM
35
UBS AM
Illinois
$10.8M +$9.7M +254,509 New
EAM
36
Eventide Asset Management
Massachusetts
$10.6M +$9.53M +250,000 New
Lord, Abbett & Co
37
Lord, Abbett & Co
New Jersey
$9.69M +$8.67M +227,392 New
Wellington Management Group
38
Wellington Management Group
Massachusetts
$9.4M +$8.42M +220,788 New
FIM
39
Fernwood Investment Management
Massachusetts
$7.05M +$6.32M +165,639 New
GC
40
Grace Capital
Massachusetts
$7M +$6.27M +164,389 New
Charles Schwab
41
Charles Schwab
California
$6.6M +$5.91M +155,043 New
TG
42
TCW Group
California
$6.04M +$5.41M +141,935 New
N
43
Nuveen
North Carolina
$5.37M +$4.81M +126,039 New
American Century Companies
44
American Century Companies
Missouri
$5.26M +$4.71M +123,550 New
Goldman Sachs
45
Goldman Sachs
New York
$4.53M +$4.06M +106,359 New
Morgan Stanley
46
Morgan Stanley
New York
$4.44M +$3.98M +104,325 New
LGM
47
Logos Global Management
California
$4.26M +$3.81M +100,000 New
IC
48
Iconiq Capital
California
$4.03M +$3.61M +94,697 New
Bank of New York Mellon
49
Bank of New York Mellon
New York
$3.79M +$3.4M +89,053 New
RCM
50
Ratan Capital Management
Florida
$2.98M +$2.67M +70,000 New
1
2
3 4

RLAY Hedge Fund Activity: Q3 2020 in Review

94 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Relay Therapeutics (RLAY) for Q3 2020, worth a combined $3.64B.

Buyers outnumbered sellers: 94 funds opened new RLAY positions and 0 closed out — a net gain of 94 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was SB Investment Advisers (UK), opening a new position worth an estimated $1.06B.

  • 94 institutional investors held Relay Therapeutics (RLAY) as of Q3 2020, up from 0 in Q2 2020.
  • Funds reported $3.64B of Relay Therapeutics stock for Q3 2020.
  • 94 funds opened new Relay Therapeutics positions in Q3 2020 and 0 closed out, a net change of +94 holders.
  • The largest Relay Therapeutics buyer in Q3 2020 was SB Investment Advisers (UK), an estimated $1.06B added.

Based on aggregated 13F filings for Q3 2020.